Company intelligence / Profile preview

Asofarma

Guatemala City, Guatemalaasofarma-ca.com ↗

Ownership: Private
Employees: ~897
Development stage: Commercial

Overview

Asofarma operates across Central America and the Caribbean with a broad commercial portfolio focused on innovative therapies. The company has played a key role in distributing COVID vaccines such as Moderna's Spikevax in the region. Clinical results for specific programs are not detailed publicly but the company emphasizes high-quality standards and regulatory compliance.

Therapeutic areas: OtherInfectious Diseases
Modalities: Small molecules (inferred from broad pharmaceutical portfolio)Vaccines (e.g., Spikevax COVID vaccine)
Industry: Consulting

Partnerships

Moderna Inc. for distribution/marketing of COVID‑19 vaccines in Central America & Caribbean

Beyond the preview

Go deeper on Asofarma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Asofarma.

Explore the full profile